Project Grant K23AA033445
Award Date 8/20/26
Completion Date 7/31/31
Dollars Obligated $192K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Colorado-Denver $191,592 on August 19, 2026, under the Alcohol Research Programs (CFDA 93.273) to support a five-year mentored research project on enhancing emergency department care for alcohol use disorder. Dr. Jacob Lebin will develop and test an electronic health record-embedded clinical decision support tool designed to improve identification and treatment of alcohol use disorder in emergency department...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Colorado-Denver $189,532 on August 19, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and test a peer-narrated video decision aid for alcohol treatment tailored to intensive care unit survivors with alcohol use disorder. The award funds a five-year career development project (K23) led by Dr. Kelsey Hills-Dunlap. The research addresses a gap identified in prior work: ICU survivors with alcohol use...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $140,340 on December 1, 2025, under the Alcohol Research Programs (CFDA 93.273) for a Project Grant investigating the role of the C5 complosome in ethanol-induced immunometabolic dysregulation of Kupffer cells in alcohol-associated liver disease. The funded research defines novel mechanisms of alcohol-induced metabolic reprogramming of Kupffer...
- The National Institute on Alcohol Abuse and Alcoholism awarded the Regents of the University of Colorado, doing business as University of Colorado-Denver, $1,162,583 on September 10, 2025, under the Alcohol Research Programs (CFDA 93.273) to conduct research combining laboratory-based pain induction and ecological momentary assessment (EMA) methods to examine age-related differences in the relationship between alcohol use, pain, and inflammation. The research tests two hypotheses: that pain...
- The National Institute on Alcohol Abuse and Alcoholism awarded Duke University $2,725,992 under the Alcohol Research Programs (CFDA 93.273) on September 1, 2026, to assess the impact of three employer-sponsored strategies on alcohol use disorder (AUD) detection, treatment, and health outcomes among working-age adults with private insurance. The project will evaluate whether expanding clinician provider networks, reducing out-of-pocket financial barriers to care, and implementing...
- The National Institute on Alcohol Abuse and Alcoholism, part of the Department of Health and Human Services National Institutes of Health, awarded $702,720 to Indiana University Indianapolis on August 10, 2026, under the Alcohol Research Programs (CFDA 93.273) project grant R01AA031671. The award funds research investigating posterior default mode network modulation as a treatment target in alcohol use disorder. The research examines how dysfunction in the medial posterior default mode...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Pittsburgh $903,936 on September 20, 2025, under the Alcohol Research Programs (CFDA 93.273) to investigate mechanisms of alcohol's effects on prefrontal cortex circuits, with performance through July 31, 2030, in Pittsburgh, Pennsylvania. The research examines how vasoactive intestinal peptide–expressing inhibitory interneurons (VIP-INs) in the prefrontal cortex modulate drinking behavior and affective changes in...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Johns Hopkins University $766,320 on August 10, 2026, under the Alcohol Research Programs (CFDA 93.273) to characterize the health care settings where women with alcohol use disorder receive initial diagnosis and identify missed opportunities for earlier intervention and engagement in treatment. The research assembles diverse data sources from 2016 through 2029, including Medicare, Medicaid, and commercial insurance claims...
- The National Institute on Alcohol Abuse and Alcoholism awarded Loyola University of Chicago Health Sciences Campus $115,500 on August 17, 2026, under the Alcohol Research Programs (CFDA 93.273) to identify leading causes and pathways of death in alcoholic acute respiratory distress syndrome (ARDS) patients through computational analysis of clinical trial datasets. The recipient will conduct a retrospective cohort study validating findings across five NIH-funded, multicenter, randomized,...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Texas at Arlington $596,443 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct a randomized controlled trial examining the effect of alcohol abstinence on cardiovascular disease risk factors. The research will enroll men and women who drink above recommended limits but are free of alcohol use disorder and cardiovascular disease. The study employs a novel alcohol abstinence...